Tachykinins and tachykinin receptors: a growing family

被引:379
作者
Pennefather, JN
Lecci, A
Candenas, ML
Patak, E
Pinto, FM
Maggi, CA
机构
[1] Ctr Invest Cientificas Isla La Cartuja, Inst Invest Quim, Seville 41092, Spain
[2] Monash Univ, Victorian Coll Pharm, Dept Pharmaceut Biol & Pharmacol, Parkville, Vic 3052, Australia
[3] Menarini Ric SpA Res Labs, Dept Pharmacol, I-50131 Florence, Italy
[4] Royal Hosp Women, Dept Anaesthet, Carlton, Vic 3053, Australia
关键词
tachykinins; tachykinin receptors; substance P; neurokinin A; neurokinin B; endokinins A; B; C; D;
D O I
10.1016/j.lfs.2003.09.039
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The peptides of the tachykinin family are widely distributed within the mammalian peripheral and central nervous systems and play a well-recognized role as excitatory neurotransmitters. Currently, the concept that tachykinins act exclusively as neuropeptides is being challenged, since the best known members of the family, substance P, neurokinin A and neurokinin B, are also present in non-neuronal cells and in non-innervated tissues. Moreover, the recently cloned mammalian tachykinins hemokinin-1 and endokinins are primarily expressed in non-neuronal cells, suggesting a widespread distribution and important role for these peptides as intercellular signaling molecules. The biological actions of tachykinins are mediated through three types of receptors denoted NK1, NK2 and NK3 that belong to the family of G protein-coupled receptors. The identification of additional tachykinins. has reopened the debate of whether more tachykinin receptors exist. In this review, we summarize the current knowledge of tachykinins and their receptors. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1445 / 1463
页数:19
相关论文
共 135 条
[21]   Substance P and its receptor neurokinin 1 expression in asthmatic airways [J].
Chu, HW ;
Kraft, M ;
Krause, JE ;
Rex, MD ;
Martin, RJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (04) :713-722
[22]   In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips [J].
Croci, T ;
Aureggi, G ;
Manara, L ;
Emonds-Alt, X ;
Le Fur, G ;
Maffrand, JP ;
Mukenge, S ;
Ferla, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) :1321-1327
[23]   Altered nociception, analgesia and aggression in mice lacking the receptor for substance P [J].
De Felipe, C ;
Herrero, JF ;
O'Brien, JA ;
Palmer, JA ;
Doyle, CA ;
Smith, AJH ;
Laird, JMA ;
Belmonte, C ;
Cervero, F ;
Hunt, SP .
NATURE, 1998, 392 (6674) :394-397
[24]  
Donaldson LF, 1996, BIOCHEM J, V320, P1
[25]   STRUCTURE AND PHARMACOLOGICAL ACTIONS OF ELEDOISIN, ACTIVE ENDECAPEPTIDE OF POSTERIOR SALIVARY GLANDS OF ELEDONE [J].
ERSPAMER, V ;
ANASTASI, A .
EXPERIENTIA, 1962, 18 (02) :58-&
[26]  
FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
[27]   Intestinal anti-nociceptive behaviour of NK3 receptor antagonism in conscious rats:: evidence to support a peripheral mechanism of action [J].
Fioramonti, J ;
Gaultier, E ;
Toulouse, M ;
Sanger, GJ ;
Bueno, L .
NEUROGASTROENTEROLOGY AND MOTILITY, 2003, 15 (04) :363-369
[28]  
FONG TM, 1992, MOL PHARMACOL, V41, P24
[29]   Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer [J].
Friess, H ;
Zhu, ZW ;
Liard, V ;
Shi, X ;
Shrikhande, SV ;
Wang, L ;
Lieb, K ;
Korc, M ;
Palma, C ;
Zimmermann, A ;
Reubi, JC ;
Büchler, MW .
LABORATORY INVESTIGATION, 2003, 83 (05) :731-742
[30]   Functional coupling of the human dopamine D2 receptor with Gαi1, Gαi2, Gαi3 and Gαo G proteins:: evidence for agonist regulation of G protein selectivity [J].
Gazi, L ;
Nickolls, SA ;
Strange, PG .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (05) :775-786